| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| May 27, 2016 | PBH Prestige Consumer Healthcare Inc. | Cowley Samuel C54 | General Counsel And VP | Sell | 32,599 | $54.67 | $1,782,187.33 | -25.2% | |
| May 27, 2016 | PBH Prestige Consumer Healthcare Inc. | Migaki Paul | See Remarks | Sell | 26,877 | $54.51 | $1,465,065.27 | -13.8% | |
| May 26, 2016 | EBS Emergent Biosolutions Inc. | El-Hibri Fuad | Chairman | Sell | 39,759 | $43.13 | $1,714,760.10 | -1.2% | |
| May 26, 2016 | CPIX Cumberland Pharmaceuticals Inc | Lawrence Thomas R | Director | Sell | 3,000 | $4.55 | $13,650.00 | -5.8% | |
| May 25, 2016 | IRWD Ironwood Pharmaceuticals Inc | Gilbert Halley E | Chief Legal Officer | Sell | 20,275 | $12.19 | $247,152.25 | -23.9% | |
| May 25, 2016 | SCYX Scynexis Inc | Taglietti Marco | Chief Executive Officer | Buy | 5,754 | $3.26 | $18,758.04 | +4.8% | |
| May 25, 2016 | AMPH Amphastar Pharmaceuticals, Inc. | Shandell Jason B. | President | Sell | 1,074 | $15.60 | $16,754.40 | -0.5% | |
| May 25, 2016 | SCYX Scynexis Inc | Hanham Ann | Director | Buy | 4,225 | $3.64 | $15,379.00 | New | |
| May 25, 2016 | SCYX Scynexis Inc | Taglietti Marco | Chief Executive Officer | Buy | 246 | $3.20 | $787.20 | +0.2% | |
| May 25, 2016 | EBS Emergent Biosolutions Inc. | Harsanyi Zsolt | Director | Sell | 27,867 | $42.33 | $1,179,511.47 | -13.9% | |
| May 25, 2016 | EBS Emergent Biosolutions Inc. | El-Hibri Fuad | Chairman | Sell | 85,000 | $42.52 | $3,614,300.00 | -1.2% | |
| May 24, 2016 | SCYX Scynexis Inc | Taglietti Marco | Chief Executive Officer | Buy | 5,500 | $3.37 | $18,535.00 | +4.8% | |
| May 23, 2016 | SCYX Scynexis Inc | Taglietti Marco | Chief Executive Officer | Buy | 7,500 | $3.14 | $23,580.00 | +3.5% | |
| May 23, 2016 | CVSI Cv Sciences, Inc. | Raskin Larry Phillip | Director | Buy | 100,000 | $0.47 | $46,510.50 | +5.5% | |
| May 20, 2016 | EBS Emergent Biosolutions Inc. | Abdun-Nabi Daniel | President &CEO | Sell | 8,701 | $42.00 | $365,442.00 | -4.6% | |
| May 20, 2016 | DVAX Dynavax Technologies Corp | Gray Eddie | CEO And Director | Buy | 2,750 | $15.57 | $42,819.50 | +36.4% | |
| May 20, 2016 | MRK Merck & Co., Inc. | Golestani Clark | EVP &Chief Info Officer | Sell | 39,877 | $54.79 | $2,184,952.10 | -53.9% | |
| May 19, 2016 | EBS Emergent Biosolutions Inc. | Hauer Jerome M | Director | Sell | 3,134 | $41.22 | $129,183.48 | -15.6% | |
| May 19, 2016 | PAHC Phibro Animal Health Corp | Corcoran E Thomas61 | Director | Buy | 5,000 | $18.14 | $90,700.00 | +100.0% | |
| May 19, 2016 | SCYX Scynexis Inc | Taglietti Marco | Chief Executive Officer | Buy | 6,000 | $3.07 | $18,420.00 | +6.0% | |
| May 18, 2016 | AMPH Amphastar Pharmaceuticals, Inc. | Gerst Diane G. | EVP, Qa &Regulatory Affairs | Sell | 1,427 | $13.97 | $19,939.33 | -4.7% | |
| May 17, 2016 | AMPH Amphastar Pharmaceuticals, Inc. | Prins Richard K61 | Director | Sell | 3,200 | $13.56 | $43,391.36 | -12.2% | |
| May 16, 2016 | AVDL Avadel Pharmaceuticals Plc | Stapleton Craig R | Director | Buy | 27,228 | $9.21 | $250,891.29 | +2.8% | |
| May 13, 2016 | TLPH Talphera, Inc. | Rosen Howard B | CEO | Buy | 10,206 | $3.26 | $33,271.56 | +25.6% | |
| May 13, 2016 | EBS Emergent Biosolutions Inc. | Sullivan Louis W62 | Director | Sell | 47,631 | $39.21 | $1,867,761.00 | -29.5% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.